Prostate cancer Board decisions

The Veteran's prostate cancer is granted as service connected due to exposure to herbicide Agent Orange during his duty in the Demilitarized Zone (DMZ) of Korea.

The Veteran's claims for prostate cancer, heart disability, mesothelioma, and kidney cancer are being remanded due to the need for additional evidence and clarification regarding his exposure to herbicide agents.

The Board has remanded the claims for service connection for Erectile Dysfunction and Prostate Cancer due to exposure to contaminated drinking water at Camp LeJeune. The case requires further examination by a subject matter expert.

The Veteran's appeal regarding the reduction in his prostate cancer residuals rating from 100% to 40% has been dismissed due to his death.

The Board has granted service connection for residuals of prostate cancer and benign urothelial hyperplasia, bladder wall, finding that the Veteran's exposure to contaminated water at Camp Lejeune during his active duty service is at least in equipoise with a link to these conditions.

The Board has granted a 60 percent rating for the Veteran's prostate cancer residuals with erectile dysfunction, effective from November 1, 2017.

The Veteran is granted a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities from February 1, 2012 to October 27, 2013 and from November 24, 2014 to July 23, 2015.

The Veteran's lymphedema is granted as secondary to his service-connected prostate cancer. The increased rating for prostate cancer prior to April 13, 2018 and the claims for sleep apnea and TDIU are remanded.

The Board has determined that the Veteran's left and right knee disabilities are not related to his active duty service.,The Veteran's prostate cancer is remanded for further development regarding exposure to herbicide agents.

The Board has remanded the Veteran's claims for service connection for various disabilities, including lumbar spine, thoracic spine, and cervical spine disabilities, gastrointestinal disability, hypertension, bilateral hearing loss, liver disability, prostate disability (including prostate cancer), and respiratory disability. The claims are related to exposure at Camp Lejeune contaminated water.

The Board has determined that the Veteran's service connection for prostate cancer should be remanded due to uncertainty regarding his service in the Republic of Vietnam and potential Agent Orange exposure.

The Board has remanded the claims for service connection for type II diabetes mellitus (DM), Parkinson’s disease, and prostate cancer due to alleged exposure to pesticides and insecticides during active service. The Veteran's claims are pending further development.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there is no medical evidence linking his current diagnosis to in-service exposure to ionizing radiation.

The Board has remanded the cases for further development due to a lack of evidence regarding herbicide exposure and service connection. The Veteran's diabetes was not shown in service nor within one year following discharge, so direct service connection is denied. Prostate cancer and right elbow conditions are also being remanded for VA examinations.

The Board has remanded the case due to incomplete information on the Veteran's income and medical expenses, which is necessary for a full decision.

The Board has determined that the Veteran's prostate cancer may be associated with presumptive exposure to Agent Orange due to his service on a ship within 12 nautical miles of the coast of Vietnam. However, this determination is contingent upon further clarification regarding the specific circumstances of his service.

The Veteran's prostate cancer is currently rated as 100% permanent and total due to active malignancy, but the RO notes there is a likelihood of improvement. The Board finds the evidence unclear and conflicting regarding the remission status and severity of his prostate cancer.

The Board has denied the Veteran's claims for increased ratings for narcolepsy and hypertension. The prostate cancer claim is remanded due to inadequate VA examination, and the kidney disability and bilateral lower extremity disability claims are also remanded.,Further evaluations by VA are needed to address the Veteran’s prostate cancer, kidney disability, and bilateral lower extremity disabilities.

The Veteran's increased rating claims for prostate cancer, right scapula shell fragment wounds, and left ilio-inguinal nerve disability are remanded. Additionally, the issue of entitlement to special monthly compensation based on 38 U.S.C. § 1114(s) is also remanded.